Gilead Sciences, Inc.Pembelian
Time to get long GILD
Gilled is an extremely strong company fundamentally with huge earnings growth. Stock was hid with uncertainty with competition or ABBY but their new Hep C drugs should still control 80-90% of market share. Also the retracement off the recent high has found solid support at the $100 level. The stock looks ready for a move higher
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.